期刊文献+

高剂量曲美他嗪对扩张型心肌病心衰患者预后影响 被引量:15

High dose of trimetazidine on the prognosis of patients with dilated cardiomyopathy and heart failure
下载PDF
导出
摘要 目的分析高剂量曲美他嗪(120 mg/d)对扩张型心肌病(DCM)心衰患者预后的影响。方法选取西京医院心内科及沈阳军区总医院心内科2014年出院的DCM心衰患者150例,随访1~2年,失访14例,最终纳入136例患者。按曲美他嗪使用剂量将患者分为高剂量组(40 mg,每天3次,n=13)、常规剂量组(20 mg,每天3次,n=99)及对照组(未服用,n=24),比较3组患者用药前后心功能、影像学改变及代谢相关指标的差异。结果高剂量组患者年龄、射血分数(EF)值均偏低(P<0.05);左心室收缩内径(LVESD)、CO、缩短分数(FS)、每搏输出量(SV)值均偏高(P<0.05);主要合并用药包括血管紧张素转换酶抑制剂或血管紧张素受体拮抗剂(100%)、利尿剂(76.92%)及洋地黄(76.92%)。服用药物1~2年后,高剂量组患者脑钠肽、FS值、EF值均较常规剂量组明显减小,LVESD值较常规剂量组明显增大。高剂量与常规剂量的曲美他嗪均可降低CO值,且SV值改变均较对照组大。结论高剂量曲美他嗪常被用于病情偏重患者,但其疗效一般,仍需进一步证实。 Objective To analyze high dose (120 mg/day) of trimetazidine (TMZ) on dilated cardiomyopathy (DCM) affects the prognosis of patients with heart failure. Methods A retrospective study was performed on 150 DCM patients who were admitted in Xi- jing Hospital and The General Hospital of Shenyang Military Command in 2014. Patients were followed up for 1 to 2 years, 14 cases were lost, 136 cases were involved. According to the different dose of TMZ, patients were divided into the high dose group (40 mg, 3 times/day, n = 13 ), the conventional dose group ( 20 mg, 3 times/day, n = 99 ) and the control group ( without taking, n = 24), the three groups were compared before and after treatment in cardiac morphology change, function and related-metabolism index. Results The age, ejection fraction(EF) values of high dose group of patients were low( P 〈 0. 05 ) ;left ventricular systolic diameter( LVESD), CO, shortening fraction ( fractional shortening, FS ), stroke volume ( SV ) values were high ( P 〈 0. 05 ) ; ACEI or ARB ( 100% ), diuretics (76. 92% ) and digitalis(76. 92% ). After medicine taken 1 to 2 years later, BNP, FS value, EF value in high dose group decreased significantly than those in the conventional dose group, LVESD value was significantly increased than that in the conventional dose group. High dose and regular doses of TMZ can reduce CO value, and the SV values changed more than that in the control group. Con- clusion High dose of TMZ is often used in patients with severe disease,its efficacy is generally and needed to be further confirmed. Key words: High dose ; Trimetazidine; Dilated cardiomyopathy; Heart failure
出处 《临床军医杂志》 CAS 2017年第5期501-503,507,共4页 Clinical Journal of Medical Officers
关键词 高剂量 曲美他嗪 扩张型心肌病 心衰 High dose Trimetazidine Dilated cardiomyopathy Heart failure
  • 相关文献

参考文献6

二级参考文献46

  • 1心肌病诊断与治疗建议[J].中华心血管病杂志,2007,35(1):5-16. 被引量:547
  • 2Maron B J, Towbin J A, Thiene G, et al. Contemporary definitions and classification of the cardiomyopathies~ an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee. Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention[J]. Circulation,2006,113(14) : 1807-1816.
  • 3Guyatt G H, Sullivan M J, Thompson P J, et al. The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure[J]. Can Med Assoc J,1985,132(8):919-923.
  • 4Rector T S, Kubo S H, Cohn J N. Validity of the Minnesota living with heart failure questionnaire as a measure of therapeutic response to enalapril or placebo[J]. Am J Cardiol, 1993,71 (12): 1106-1107.
  • 5Killalea S M, Krum H. Systematic review of the efficacy and safety of perhexiline in the treatment of ischemic heart disease [J]. Am J Cardiovasc Drugs,2001,1(3):193-204.
  • 6Sisakian H, Torgomyan A, Barkhudaryan A. The effect of trimetazidine on left ventricular systolic function and physical tolerance in patients with ischemic cardiomyopathy [J]. Acta Cardiol,2007,62(5):493-499.
  • 7Peng Zhao,Jie Zhang,Xian-Gang Yin,Preben Maharaj,Sharmain Narraindoo,Lian-Qun Cui,Yuan-Sheng Tang.The effect of trimetazidine on cardiac function in diabetic patients with idiopathic dilated cardiomyopathy[J]. Life Sciences . 2012
  • 8Wang Wenmeng,Tang Qizhu.Early administration of trimetazidine may prevent or ameliorate diabetic cardiomyopathy[J]. Medical Hypotheses . 2010 (2)
  • 9Giuseppe Marazzi,Otavio Gebara,Cristiana Vitale,Giuseppe Caminiti,Mauricio Wajngarten,Maurizio Volterrani,José A. F. Ramires,Giuseppe Rosano,Massimo Fini.Effect of trimetazidine on quality of life in elderly patients with ischemic dilated cardiomyopathy[J]. Advances in Therapy . 2009 (4)
  • 10Romualdo Belardinelli,Francesca Lacalaprice,Ernesto Faccenda,Loretta Volpe.Trimetazidine potentiates the effects of exercise training in patients with ischemic cardiomyopathy referred for cardiac rehabilitation[J]. European Journal of Cardiovascular Prevention & Rehabilitation . 2008 (5)

共引文献72

同被引文献96

引证文献15

二级引证文献80

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部